| Kimberly Ann Donnellan, MD | |
|
6701 Airport Blvd Ste B123, Mobile, AL 36608-6775 | |
| (251) 660-3495 | |
| Not Available |
| Full Name | Kimberly Ann Donnellan |
|---|---|
| Gender | Female |
| Speciality | Otolaryngology |
| Experience | 19 Years |
| Location | 6701 Airport Blvd Ste B123, Mobile, Alabama |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1376762815 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Y00000X | Otolaryngology | MD.31033 (Alabama) | Primary |
| 207Y00000X | Otolaryngology | T1792 (Mississippi) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Usa Health University Hospital | Mobile, AL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Of South Alabama Health Care Authority | 4082986088 | 107 |
News Archive
HITLAB has selected five finalists for its HITLAB World Cup, an international competition that promotes original solutions to pressing healthcare challenges. The best and brightest in healthcare innovation, the finalists, will present their ideas at the HITLAB Innovators SummitSM on December 4, 2015, at Columbia University's Alfred Lerner Hall.
A new drug with the potential to reverse or slow the development of asthma is being tested by researchers at The University of Queensland.
The immune system may play a critical role in ensuring the success of certain types of cancer therapies, according to a new study by researchers at the Stanford University School of Medicine. The research showed treatments that disable cancer-promoting genes called oncogenes are much more successful in eradicating tumors in the presence of a signaling molecule secreted by kind of immune cell called a T helper cell.
There is an urgent reason to study stem cells: stem cells are at the heart of some, if not all, cancers. Mounting evidence implicates a clutch of rogue stem cells brandishing 'epigenetic' marks as the main culprits in cancer. Wiping out tumours for good, some biologists believe, depends on uprooting these wayward stem cells.
› Verified 7 days ago
| Entity Name | Providence Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952390643 PECOS PAC ID: 9830111871 Enrollment ID: O20051219000880 |
News Archive
HITLAB has selected five finalists for its HITLAB World Cup, an international competition that promotes original solutions to pressing healthcare challenges. The best and brightest in healthcare innovation, the finalists, will present their ideas at the HITLAB Innovators SummitSM on December 4, 2015, at Columbia University's Alfred Lerner Hall.
A new drug with the potential to reverse or slow the development of asthma is being tested by researchers at The University of Queensland.
The immune system may play a critical role in ensuring the success of certain types of cancer therapies, according to a new study by researchers at the Stanford University School of Medicine. The research showed treatments that disable cancer-promoting genes called oncogenes are much more successful in eradicating tumors in the presence of a signaling molecule secreted by kind of immune cell called a T helper cell.
There is an urgent reason to study stem cells: stem cells are at the heart of some, if not all, cancers. Mounting evidence implicates a clutch of rogue stem cells brandishing 'epigenetic' marks as the main culprits in cancer. Wiping out tumours for good, some biologists believe, depends on uprooting these wayward stem cells.
› Verified 7 days ago
| Entity Name | Alabama Providence Healthcare Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1245669514 PECOS PAC ID: 9638308430 Enrollment ID: O20140127000341 |
News Archive
HITLAB has selected five finalists for its HITLAB World Cup, an international competition that promotes original solutions to pressing healthcare challenges. The best and brightest in healthcare innovation, the finalists, will present their ideas at the HITLAB Innovators SummitSM on December 4, 2015, at Columbia University's Alfred Lerner Hall.
A new drug with the potential to reverse or slow the development of asthma is being tested by researchers at The University of Queensland.
The immune system may play a critical role in ensuring the success of certain types of cancer therapies, according to a new study by researchers at the Stanford University School of Medicine. The research showed treatments that disable cancer-promoting genes called oncogenes are much more successful in eradicating tumors in the presence of a signaling molecule secreted by kind of immune cell called a T helper cell.
There is an urgent reason to study stem cells: stem cells are at the heart of some, if not all, cancers. Mounting evidence implicates a clutch of rogue stem cells brandishing 'epigenetic' marks as the main culprits in cancer. Wiping out tumours for good, some biologists believe, depends on uprooting these wayward stem cells.
› Verified 7 days ago
| Entity Name | University Of South Alabama Health Care Authority |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1508392432 PECOS PAC ID: 4082986088 Enrollment ID: O20170825003180 |
News Archive
HITLAB has selected five finalists for its HITLAB World Cup, an international competition that promotes original solutions to pressing healthcare challenges. The best and brightest in healthcare innovation, the finalists, will present their ideas at the HITLAB Innovators SummitSM on December 4, 2015, at Columbia University's Alfred Lerner Hall.
A new drug with the potential to reverse or slow the development of asthma is being tested by researchers at The University of Queensland.
The immune system may play a critical role in ensuring the success of certain types of cancer therapies, according to a new study by researchers at the Stanford University School of Medicine. The research showed treatments that disable cancer-promoting genes called oncogenes are much more successful in eradicating tumors in the presence of a signaling molecule secreted by kind of immune cell called a T helper cell.
There is an urgent reason to study stem cells: stem cells are at the heart of some, if not all, cancers. Mounting evidence implicates a clutch of rogue stem cells brandishing 'epigenetic' marks as the main culprits in cancer. Wiping out tumours for good, some biologists believe, depends on uprooting these wayward stem cells.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kimberly Ann Donnellan, MD Po Box 850489, Mobile, AL 36685-0489 Ph: (251) 342-3949 | Kimberly Ann Donnellan, MD 6701 Airport Blvd Ste B123, Mobile, AL 36608-6775 Ph: (251) 660-3495 |
News Archive
HITLAB has selected five finalists for its HITLAB World Cup, an international competition that promotes original solutions to pressing healthcare challenges. The best and brightest in healthcare innovation, the finalists, will present their ideas at the HITLAB Innovators SummitSM on December 4, 2015, at Columbia University's Alfred Lerner Hall.
A new drug with the potential to reverse or slow the development of asthma is being tested by researchers at The University of Queensland.
The immune system may play a critical role in ensuring the success of certain types of cancer therapies, according to a new study by researchers at the Stanford University School of Medicine. The research showed treatments that disable cancer-promoting genes called oncogenes are much more successful in eradicating tumors in the presence of a signaling molecule secreted by kind of immune cell called a T helper cell.
There is an urgent reason to study stem cells: stem cells are at the heart of some, if not all, cancers. Mounting evidence implicates a clutch of rogue stem cells brandishing 'epigenetic' marks as the main culprits in cancer. Wiping out tumours for good, some biologists believe, depends on uprooting these wayward stem cells.
› Verified 7 days ago
Ronnie Everett Swain Sr., M.D. Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 2880 Dauphin St, Mobile, AL 36606 Phone: 251-473-1900 Fax: 251-470-8943 | |
Frederick M. Silver, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 2451 Fillingim St, Mastin 101, Mobile, AL 36617 Phone: 251-445-8282 Fax: 251-445-8281 | |
James Kent Pitcock, M.D. Otolaryngology Medicare: Medicare Enrolled Practice Location: 3701 Dauphin St, Mobile, AL 36608 Phone: 251-341-3368 Fax: 251-341-3371 | |
Mark Richard Gacek, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 720 Hillcrest Rd Ste A, Mobile, AL 36695 Phone: 251-340-7970 Fax: 866-873-8411 | |
Kent L. Burton, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 2880 Dauphin St, Mobile, AL 36606 Phone: 251-473-1900 Fax: 251-470-8943 | |
Wiley Hugh Justice, M.D. Otolaryngology Medicare: Medicare Enrolled Practice Location: 5721 Usa North Dr, Hahn 1119, Mobile, AL 36688 Phone: 251-445-9378 Fax: 251-445-9377 | |
Dr. Richard Lewis Palesano, MD Otolaryngology Medicare: Medicare Enrolled Practice Location: 2880 Dauphin St, Mobile, AL 36606 Phone: 251-473-1900 Fax: 251-470-8940 |